Drug
Who makes canakinumab?
2 companies list canakinumab as a human prescription drug, including under the names Ilaris. Forms: injection, solution. Routes: subcutaneous.
Labellers from the openFDA NDC Directory. A labeller is the firm named on the label, not necessarily the site that made the product, and a listing is not an FDA approval. Data as of 24 Sept 2026. Methodology
Companies listing canakinumab
| Company | Forms | Application | NDCs | Registered sites |
|---|---|---|---|---|
| Novartis Pharmaceuticals CorporationSwitzerland | injection, solution | BLABLA125319 | 1 | 20 |
| Novartis Pharma Stein AG | injection, solution | DRUG FOR FURTHER PROCESSING | 1 | 0 |
Bulk ingredient listings
- Novartis Pharmaceuticals CorporationSwitzerland · 1 NDC
Enquiry
Common questions
- Who makes canakinumab?
- 2 companies list canakinumab as a human prescription drug in the openFDA NDC Directory, led by Novartis Pharmaceuticals Corporation, Novartis Pharma Stein AG. Each is the labeller, the firm named on the label; the product may be made at a site registered to another company.
- Who supplies canakinumab active ingredient?
- 1 company lists canakinumab as a bulk ingredient, including Novartis Pharmaceuticals Corporation.